Kite Pharma Obtains $15,000,000 Series A Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=999262a5-b0d6-4ccc-83c2-57fac6ae52af&Preview=1 -
Date
3/9/2011 -
Company Name
Kite Pharma -
Mailing Address
10924 Le Conte Avenue Los Angeles, CA 90024 -
Company Description
Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient’s own immune system to fight tumor cells. -
Website
http://www.kitepharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$15,000,000 -
Transaction Round
Series A -
Proceeds Purposes
The funds will allow us to grow the company, advance our products into clinical development and to expand our pre-clinical pipeline. -
M&A Terms
-
Venture Investor
TPG Capital -
Venture Investor
Undisclosed
